Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BGI Co-Win

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 14
Rounds per year 1.75
Lead investments 0
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Medical Device

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BGI Co-Win:
Typical Co-investors
BGI Co-Win is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BGI Co-Win:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Blade LLC Boston, Massachusetts, United States
BNP Paribas Fortis Belgium, Brussels, Brussels Hoofdstedelijk Gewest
CKA Capital Ltd England, London, United Kingdom
Contrary California, San Francisco, United States
Hua Capital Beijing, Beijing, China
Huayu Investment Beijing, Beijing, China
Jet Propulsion Laboratory California, Pasadena, United States
Jilin Investment Group China, Jilin, Jilin
Kingfisher Capital LLC -
Launch It Capital Ltd. Israel, Tel Aviv, Tel Aviv District
Life Is Too Short Capital Guerrero, Mexico, San Pedro
Minghao -
NS Solutions Japan, Tokyo
PIA Japan, Minato
REALITY ACCELERATOR Chiyoda, Japan
Reflexion Capital France, Ile-de-France, Paris
Shenzhen Hexie Fazhan Touzi China, Guangdong, Shenzhen
Softfir Capital -
Suruga Bank Japan, Numazu, Shizuoka Prefecture

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

LeadBio Tech

Biotechnology
Medical
Medical Device
$15M13 Nov 2023 Hangzhou, Zhejiang, China

Waker Biology

Biopharma
Biotechnology
Pharmaceutical
20 Dec 2022 Minhang, Shanghai, China

Yingshu Life

Health Care
Hospital
Medical Device
22 Nov 2022 Shenzhen, Guangdong, China

Ubrigene

$15M01 Sep 2022 -

Hemu Gene

Biopharma
Biotechnology
Health Care
Medical
$4M15 Aug 2022 China, China

YZY Bio

Biotechnology
Health Care
Pharmaceutical
Product Research
$38M13 Sep 2021 Wuhan, Hubei, China

Realmind Biotech

Biotechnology
Health Diagnostics
Medical Device
19 Jul 2021 Nanjing, Jiangsu, China

ToloBio

Biotechnology
Health Diagnostics
Medical
$1M07 Aug 2020 Shanghai, Shanghai, China

Targene Medical

Biotechnology
$15M27 Mar 2020 Yuexiu District, Guangdong Province, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BGI Co-Win?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 14
Average round size 10M
Rounds per year 1.75
Peak activity year 2020
Lead investments 0
Group Appearance index 0.64

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

LeadBio Tech

Biotechnology
Medical
Medical Device
$15M13 Nov 2023 Hangzhou, Zhejiang, China

Waker Biology

Biopharma
Biotechnology
Pharmaceutical
20 Dec 2022 Minhang, Shanghai, China

Yingshu Life

Health Care
Hospital
Medical Device
22 Nov 2022 Shenzhen, Guangdong, China

Ubrigene

$15M01 Sep 2022 -

Hemu Gene

Biopharma
Biotechnology
Health Care
Medical
$4M15 Aug 2022 China, China

YZY Bio

Biotechnology
Health Care
Pharmaceutical
Product Research
$38M13 Sep 2021 Wuhan, Hubei, China

Realmind Biotech

Biotechnology
Health Diagnostics
Medical Device
19 Jul 2021 Nanjing, Jiangsu, China

ToloBio

Biotechnology
Health Diagnostics
Medical
$1M07 Aug 2020 Shanghai, Shanghai, China

Targene Medical

Biotechnology
$15M27 Mar 2020 Yuexiu District, Guangdong Province, China
Crunchbase icon

Content report

The following text will be sent to our editors: